Ibandronate Sodium Monohydrate is a bisphosphonate medication. It is used in the prevention and treatment of osteoporosis and metastasis-associated skeletal fractures in people with cancer. Reference standards of Ibandronate Sodium Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ibandronate Sodium Monohydrate
Catalogue No.:PA 09 44000
CAS :
Molecular Formula : C9H24NNaO8P2
Molecular Weight : 359.23
3-[Methyl(pentyl)amino]propanoic Acid
Catalogue No.:PA 09 44010
Molecular Formula : C9H19NO2
Molecular Weight : 173.25
[1-Hydroxy-3-(pentylamino)propane-1,1-diyl]bis(Phosphonic Acid)
Catalogue No.:PA 09 44030
Molecular Formula : C8H21NO7P2
Molecular Weight : 305.2
3-(N-Methyl-N-pentylamino)propionic Acid Hydrochloride
Catalogue No.:PA 09 0440011
Molecular Formula : C9H20ClNO2
Molecular Weight : 209.71
[1-Hydroxy-3-(pentylamino)propane-1,1-diyl]bis(phosphonic acid) Monosodium Salt
Catalogue No.:PA 09 0440031
Molecular Formula : C8H21NNaO7P2
Molecular Weight : 328.19
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
